A Software-Aided Approach to Reducing the Synthetic Burdens of Lead Structure Optimization
Abstract
Following the identification of a lead compound that displays activity and selectivity towards a target, the usual next step is optimization of that lead via slight structural modifications to improve or retain potency while simultaneously minimizing liabilities (ADME, toxicity). Achieving this “magic” balance of required properties for a compound to become a drug is a significant challenge. While not claiming to be a complete solution to the lead optimization process, ACD/Structure Design Suite is a software tool that significantly helps the medicinal compounds (from a database of 30,000 substituents), that are expected to produce analogs with improved selected physicochemical properties.
Following the identification of a lead compound that displays activity and selectivity towards a target, the usual next step is optimization of that lead via slight structural modifications to improve or retain potency while simultaneously minimizing liabilities (ADME, toxicity). Achieving this “magic” balance of required properties for a compound to become a drug is a significant challenge. While not claiming to be a complete solution to the lead optimization process, ACD/Structure Design Suite is a software tool that significantly helps the medicinal compounds (from a database of 30,000 substituents), that are expected to produce analogs with improved selected physicochemical properties.
Advertisement
